Product Information
VANCOMYCIN HCL 5 GM VIAL is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $39.3160 per EA under NDC 00143916301. Its NADAC has been published 52 times since Sep 18, 2024.
Strength
5.13 g/g
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00143916301
Classification
Generic
Dosage Form
INJECTION, POWDER, FOR SOLUTION
Route
INTRAVENOUS; ORAL
Last Updated
9/18/2024
Active Ingredients
VANCOMYCIN HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA210274On Market Since
2/3/2023
Pharmacological Classes
Price Statistics
The NADAC for VANCOMYCIN HCL 5 GM VIAL has been published 52 times since Sep 18, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $39.3160 per EA |
|---|---|
| All-time high | $39.3160 (Sep 10, 2025) |
| All-time low | $39.3160 (Sep 18, 2024) |
| 52-week high | $39.3160 |
| 52-week low | $39.3160 |
| Median price | $39.3160 |
| Average price | $39.3160 |
| Largest weekly change | 0.0% (Sep 25, 2024) |
| Weeks tracked | 52 |
| Tracking since | Sep 18, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the vancomycin hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of VANCOMYCIN HCL 5 GM VIAL?
The current National Average Drug Acquisition Cost (NADAC) for VANCOMYCIN HCL 5 GM VIAL, manufactured by Hikma Pharmaceuticals USA Inc., is $39.3160 per EA (NDC 00143916301), effective Sep 10, 2025.
How has the price of VANCOMYCIN HCL 5 GM VIAL changed over time?
Over the history we have for it, the NADAC for VANCOMYCIN HCL 5 GM VIAL has held within roughly two percent of its current level. It has been tracked across 52 weekly CMS publications since Sep 18, 2024.
What are the highest and lowest recorded NADAC prices for VANCOMYCIN HCL 5 GM VIAL?
Since Sep 18, 2024, the NADAC for VANCOMYCIN HCL 5 GM VIAL has ranged from a low of $39.3160 (Sep 18, 2024) to a high of $39.3160 (Sep 10, 2025), with a median of $39.3160 per EA.
Are there cheaper alternatives to VANCOMYCIN HCL 5 GM VIAL?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of VANCOMYCIN HCL 5 GM VIAL, so no direct lower-cost alternative is listed.
Who manufactures VANCOMYCIN HCL 5 GM VIAL?
VANCOMYCIN HCL 5 GM VIAL (NDC 00143916301) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification